During that time, he has closely followed a variety of topics of concern to those who work for, and with, pharmaceutical manufacturers - drug development, mergers and acquisitions, regulatory oversight, safety and pricing controversies, and marketing issues. For the past two years, Ed blogged about the drug industry at Pharmalot, which can now be found at twitter.com/pharmalot. Prior to joining The Star-Ledger, Ed spent six years at New York Newsday and previously worked at Investor's Business Daily. Related EditorialHow To Live on $125 a DayGenerically SpeakingPharma-ResolutionsRelated Advanced DegreesVax FixAuthentic Learning Goes to the Next LevelMagic Mushrooms